Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

NCT01473251 is registered in ClinicalTrials.gov with Vitreo-Retinal Associates, Michigan as lead sponsor.

NCT NCT01473251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01473251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration
Lead sponsor
Vitreo-Retinal Associates, Michigan
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2011
Completion date
April 30, 2014
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, exudative macular degeneration